JUSTIN PERRY: Open Payments
NPI 1649812462 · BIRMINGHAM, AL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,073 in 92 payments from 16 companies in 2025. Trend: 2023 $33 · 2024 $1,854 · 2025 $2,073
Food & beverage: $2,073
| Company | Payments | Amount |
|---|---|---|
| LEO Pharma Inc. | 14 | $413 |
| ABBVIE INC. | 15 | $350 |
| Novartis Pharmaceuticals Corporation | 13 | $292 |
| Arcutis Biotherapeutics, Inc. | 12 | $219 |
| GENZYME CORPORATION | 5 | $193 |
| PFIZER INC. | 12 | $141 |
| REVANCE THERAPEUTICS, INC. | 1 | $114 |
| Lilly USA, LLC | 4 | $81 |
| Ortho Dermatologics, a division of Bausch Health US, LLC | 4 | $68 |
| MERZ NORTH AMERICA, INC. | 2 | $56 |
Products named: ADBRY, Zoryve, COSENTYX, SKYRIZI, DUPIXENT, CIBINQO, ANZUPGO, VRAYLAR.
Industry payments across AL — which companies pay providers there.
